Hribernik, N. et al. 2026. Adjuvant nivolumab in resected oesophageal or gastroesophageal junction cancer following neoadjuvant chemoradiotherapy: Slove-nian real-world data. Radiology and Oncology. 60, 2 (Jul. 2026), 288–293.